JIR
MTEM

James Investment Research’s Molecular Templates, Inc. MTEM Stock Holding History

James Investment Research’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-501
Closed -$32K – 819
2017
Q2 		$32K Sell
501
-291
-37% -$22.9K ﹤0.01% 643
2017
Q1 		$74K Buy
792
+232
+41% +$21.7K ﹤0.01% 503
2016
Q4 		$41K Buy
560
+413
+281% +$31.5K ﹤0.01% 434
2016
Q3 		$17K Buy
+147
New +$20.2K ﹤0.01% 471

Other funds holding MTEM

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

James Investment Research's MTEM Position: Q3 2017 in Review

James Investment Research sold out of Molecular Templates, Inc. (MTEM) in Q3 2017, closing a stake of 501 shares — an estimated $32K sold.

James Investment Research first reported a position in MTEM in Q3 2016 and held it in 4 quarters. The position peaked at $74K in Q1 2017. 29 funds tracked by Wall St. Rank hold MTEM as of Q3 2017.

  • James Investment Research reported no remaining Molecular Templates, Inc. position as of Q3 2017 after selling out during the quarter.
  • James Investment Research sold 501 Molecular Templates, Inc. shares in Q3 2017, an estimated $32K.
  • James Investment Research first reported a position in Molecular Templates, Inc. in Q3 2016 and held it in 4 quarters.
  • James Investment Research's Molecular Templates, Inc. position peaked at $74K in Q1 2017.
  • 29 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2017.

Based on James Investment Research's 13F filing for Q3 2017, filed 13 Oct 2017.